Journal Finder

BioFactors is an international journal aimed at identifying and increasing our understanding of the precise biochemical effects and roles of the large number of trace substances that are required by living organisms. These include vitamins and trace elements, as well as growth factors and regulatory substances made by cells themselves. The elucidation, in a particular organism or cell line, of the roles of substances active in trace quantities, is frequently applicable directly to many other forms of life.

The aim of BAMBED is to enhance teacher preparation and student learning in Biochemistry, Molecular Biology, and related sciences such as Biophysics and Cell Biology, by promoting the world-wide dissemination of educational materials. BAMBED seeks and communicates articles on many topics, including:.

Biotechnology and Applied Biochemistry has been published continuously since its creation in 1986 (previous to that date it was called the Journal of Applied Biochemistry and was published from 1979 to 1985). Today it enjoys a superb track record, attracting distinguished authors from academia and industry from all over the world, reflecting its international status. Biotechnology and Applied Biochemistry is now published bi-monthly by Wiley-Blackwell, confirming the journal's dedication to change and commitment to rapid publication of high-quality, cutting-edge research at the interface between life sciences and their translation. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences. Promising advances in life sciences are leading to the identification of the molecular sources of disease and the creation of new generation of medicines for diseases for which there are currently either no therapies or inadequate treatments. Therapeutic proteins and antibodies are already having a significant impact in treatment of disease. Therapeutic genes and viruses promise to have an even bigger impact on human healthcare. DNA vaccine and gene-therapy are under intense development and new research areas such as tissue engineering, stem-cell therapeutics, germ-line therapy and regenerative medicines are expected to create a new wave of medicines that will make today's treatment of diseases look distinctively primitive. All this provides major challenges to life scientists and engineers engaged in discoveries and their translation to practical outcomes. Turning a new discovery into a successful application has become a highly integrated, multidisciplinary activity, and Biotechnology and Applied Biochemistry is uniquely placed to provide an international forum for the dissemination of information and discussion by researchers working across the many subject groups. The journal welcomes submissions of original articles on the following topics: nucleic acids and proteins engineering and purification; genes peptides and proteins therapy; biomaterials; biological modeling; stem cells and tissue engineering; bio-imaging; bio-sensors; biotechnology of food and natural compounds. Original papers and reviews as well as special issues can be also invited by the Editorial Board. Papers are easily submitted online at: http://mc.manuscriptcentral.com/bab.

IUBMB Life, edited by Angelo Azzi and William J. Whelan, is the flagship journal of the International Union of Biochemistry and Molecular Biology and is devoted to the rapid publication of the most novel and significant short articles, reviews and papers in the broadly defined fields of biochemistry, molecular biology, cell biology, and molecular medicine.

It is the primary objective of this publication to encourage the bridging of the gap between clinicians of all relevant specialities and biomedical scientists working in areas from biochemistry and molecular and cell biology to physiology, pharmacology and pathology. A spectrum of topics in medicine will be selected to illustrate not only the molecular insights that derive from the application of basic science, but also the variety of challenging problems that medicine is able to offer the basic scientist. The Editors and publisher anticipate that most of the authors contributing to the series will be practising clinical scientists who will develop their own personal perspective as an extended review on the molecular aspects of a field of medicine in which they are working, addressing themselves both to the doctor who is ill-at-ease with basic science, and to the basic scientist with little awareness of the problems of clinical practice.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com